Top Stories Tuesday, November 8, 2016 Bone Therapeutics has scrapped plans to trial its autologous cell therapy Preob in the U.S. The bone fracture specialist had planned to run a Phase IIb/III trial in the U.S. to complement its activities in Europe, but has pulled back from the proposal to focus on its other pipeline prospect. Tuesday, November 8, 2016 Mylan has filed for FDA approval of its biosimilar copy of Roche’s Herceptin. The submission tees up Mylan and its partner Biocon to start chipping away at a cornerstone of Roche’s business while advancing their own attempts to establish a portfolio of biosimilars in the U.S. Tuesday, November 8, 2016 Scientists from Stanford University School of Medicine have used CRISPR in early-stage work to patch up the gene that causes sickle cell disease as they eye human trials in 2018. Tuesday, November 8, 2016 Swedish biotech BioInvent has been told by the FDA to stop dosing multiple myeloma patients in its Phase II test for BI-505 due to safety concerns. Tuesday, November 8, 2016 An NIAID-funded team has discovered a Zika antibody that reduces mother-to-fetus transmission of the virus in pregnant mice. This research could lead to the development of vaccines or other therapeutics against the virus. Tuesday, November 8, 2016 With biosimilar challengers champing at the bit to snag a piece of AbbVie’s world-leading Humira sales, much is riding on the company’s IP protection. And Monday, that protection held up, notching a win in the latest battle between AbbVie and Coherus. | This week's sponsor is Catalent. | |  | eBook | Healthy Aging: Improved Dose Forms for Aging Population
As healthy aging becomes a bigger concern in the U.S., manufacturing companies are finding a new opportunities to serve this audience as they turn increasingly to OTC treatments. Download this eBook to learn how a successful partnership between OTC brands and manufacturing companies can improve health outcomes for the growing population of empowered seniors. |
| | | Asterias Biotherapeutics has given the highest dose of 20 million cells of AST-OPC1 to its first patient with complete cervical spinal cord injury. Statement Seattle Genetics and med partner Takeda have finished up patient enrollment in their late-stage study of Adcetris as a frontline combo chemotherapy in patients with CD30-positive mature T-cell lymphoma. Release An artificial intelligence company from the U.K. has penned an exclusive deal with Janssen to use AI tech with its drug development process. Statement | |
|
Resources Presented By: Lenovo Get the stats you need to start down the path to a more secure infrastructure, today. Presented By: Lenovo What's the first step to a better patient experience? The patient experience starts well before the exam room or even reception - it begins as soon as your patients pull into the parking structure. Presented by: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Presented by: DocuSign The patients who rely on your scientific leadership are expecting more. Presented by: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. Sponsored By: Salesforce Life sciences companies, like many industries today, face new challenges across the board. Read More. Presented By: ISR Reports Make essential outsourced bioprocessing decisions by staying informed of industry outsourcing practices and contract manufacturer usage patterns with ISR’s Bioprocessing Services and Technologies Market Trends and Outsourcing Dynamics report. Presented By: ISR Reports ISR’s Biosimilars in the US Oncology Market (2nd Edition) report provides data and insights from 101 US-based, board-certified oncologists/hematologist oncologists as to their expectations, fears, and aspirations for biosimilars in oncology. Presented By: ISR Reports Pinpoint the information oncologists find most valuable and the best sales channels for delivering specific types of data/information. Presented by: Covance The role of health economic data has never been more important. Presented by: Covance Leading manufacturers increasingly employ stakeholder research early in development to better identify the needs of patients and providers. Presented By: ISR Reports ISR’s Bioprocessing Market Trends and Outsourcing Dynamics: 2016-2021 report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what the marketplace will look like in five years. Presented By: ISR Reports ISR’s CRO Quality Benchmarking – Phase II/III Service Providers (8th Edition) report provides a Consumer Reports-style analysis of Phase II/III CRO service quality from hundreds of users who rated 44 Phase II/III CROs across 26 critical dimensions of quality. Presented by: Patheon Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more! Presented by: Biotech Primer This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. Sponsored by: Veeva Systems Gartner research on short- and long-term strategies for IDMP compliance. | 
